These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19934298)

  • 1. Targeting the RET pathway in thyroid cancer.
    Wells SA; Santoro M
    Clin Cancer Res; 2009 Dec; 15(23):7119-23. PubMed ID: 19934298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neural crest and multiple endocrinopathies].
    Pasini A; Michiels FM; Chappuis-Flament S; Geneste O; Rossel M; Fournier L; Feunteun J; Lenoir G; Schuffenecker I; Billaud M
    C R Seances Soc Biol Fil; 1996; 190(5-6):557-67. PubMed ID: 9074721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in-frame complex germline mutation in the juxtamembrane intracellular domain causing RET activation in familial medullary thyroid carcinoma.
    Cordella D; Muzza M; Alberti L; Colombo P; Travaglini P; Beck-Peccoz P; Fugazzola L; Persani L
    Endocr Relat Cancer; 2006 Sep; 13(3):945-53. PubMed ID: 16954442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RET receptor signaling: dysfunction in thyroid cancer and Hirschsprung's disease.
    Asai N; Jijiwa M; Enomoto A; Kawai K; Maeda K; Ichiahara M; Murakumo Y; Takahashi M
    Pathol Int; 2006 Apr; 56(4):164-72. PubMed ID: 16634961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
    Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotrophic factor receptor RET: structure, cell biology, and inherited diseases.
    Runeberg-Roos P; Saarma M
    Ann Med; 2007; 39(8):572-80. PubMed ID: 17934909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer.
    Hedayati M; Zarif Yeganeh M; Sheikholeslami S; Afsari F
    Crit Rev Clin Lab Sci; 2016 Aug; 53(4):217-27. PubMed ID: 26678667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting RET receptor tyrosine kinase activation in cancer.
    Phay JE; Shah MH
    Clin Cancer Res; 2010 Dec; 16(24):5936-41. PubMed ID: 20930041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multiple endocrine neoplasia syndromes.
    Lakhani VT; You YN; Wells SA
    Annu Rev Med; 2007; 58():253-65. PubMed ID: 17037976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins.
    Iervolino A; Iuliano R; Trapasso F; Viglietto G; Melillo RM; Carlomagno F; Santoro M; Fusco A
    Cancer Res; 2006 Jun; 66(12):6280-7. PubMed ID: 16778204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH2B1beta adaptor is a key enhancer of RET tyrosine kinase signaling.
    Donatello S; Fiorino A; Degl'Innocenti D; Alberti L; Miranda C; Gorla L; Bongarzone I; Rizzetti MG; Pierotti MA; Borrello MG
    Oncogene; 2007 Oct; 26(45):6546-59. PubMed ID: 17471236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of induced expression of MAPK phosphatase-2 in tumor development in RET-MEN2A transgenic mice.
    Hasegawa T; Enomoto A; Kato T; Kawai K; Miyamoto R; Jijiwa M; Ichihara M; Ishida M; Asai N; Murakumo Y; Ohara K; Niwa Y; Goto H; Takahashi M
    Oncogene; 2008 Sep; 27(43):5684-95. PubMed ID: 18542059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors.
    de Groot JW; Links TP; Plukker JT; Lips CJ; Hofstra RM
    Endocr Rev; 2006 Aug; 27(5):535-60. PubMed ID: 16849421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy.
    Drosten M; Pützer BM
    Nat Clin Pract Oncol; 2006 Oct; 3(10):564-74. PubMed ID: 17019434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of RET protein-tyrosine kinase inhibitors in the treatment RET-driven thyroid and lung cancers.
    Roskoski R; Sadeghi-Nejad A
    Pharmacol Res; 2018 Feb; 128():1-17. PubMed ID: 29284153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RET-mediated modulation of tumor microenvironment and immune response in multiple endocrine neoplasia type 2 (MEN2).
    Castellone MD; Melillo RM
    Endocr Relat Cancer; 2018 Feb; 25(2):T105-T119. PubMed ID: 28931560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RET inhibition: implications in cancer therapy.
    Borrello MG; Ardini E; Locati LD; Greco A; Licitra L; Pierotti MA
    Expert Opin Ther Targets; 2013 Apr; 17(4):403-19. PubMed ID: 23461584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid method for the purification of wild-type and V804M mutant ret catalytic domain: A tool to study thyroid cancer.
    Sala E; Mologni L; Cazzaniga S; Papinutto E; Gambacorti-Passerini C
    Int J Biol Macromol; 2006 Aug; 39(1-3):60-5. PubMed ID: 16490247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET Regulates Human Medullary Thyroid Cancer Cell Proliferation through CDK5 and STAT3 Activation.
    Yue CH; Oner M; Chiu CY; Chen MC; Teng CL; Wang HY; Hsieh JT; Lai CH; Lin H
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34207842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.